Formulation and food effect study of AZD1386 in Healthy Volunteers

Study identifier:D5090C00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single-Centre, Randomised, Open-Label, Five-Way Cross-Over Formulation- and Food-Effect Study in Healthy Volunteers to Assess the Pharmacokinetics of AZD1386 after Single Doses of Two Oral Solid Formulations and an Oral Solution

Medical condition

pharmacokinetics

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1386

Sex

All

Actual Enrollment

12

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Jun 2008
Primary Completion Date: 01 Aug 2008
Study Completion Date: 01 Aug 2008

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria